Precision BioSciences, Inc.
-
Ticker
DTIL
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 201-500 Employees
- Based in Durham, North Carolina
Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform. ARCUS is a highly specific and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company’s pipeline consists of multiple “off-the-shelf” CAR T immunotherapy
…More clinical candidates and several in vivo gene correction therapy candidates to cure genetic and infectious diseases where no adequate treatments exist.
Precision BioSciences, Inc.
Most Recent Responsibility Report
MOST RECENT
2022 ESG Report
Report Locked. Precision BioSciences, Inc. has reached its limit for free report views.
Our service enables potential investors to review the most recent and archived Precision BioSciences, Inc. Sustainability Report, Precision BioSciences, Inc. Corporate Social Responsibility Report, Precision BioSciences, Inc. CSR Report, Precision BioSciences, Inc. Corporate Responsibility, Precision BioSciences, Inc. CR Report, Precision BioSciences, Inc. Citizenship Report, Precision BioSciences, Inc. ESG Report, and Precision BioSciences, Inc. Environmental Report online.